Daniel Brennan
Stock Analyst at TD Cowen
(4.77)
# 574
Out of 4,407 analysts
654
Total ratings
51.1%
Success rate
15.8%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reiterated: Buy | $68 | $47.82 | +42.20% | 19 | Jun 1, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $157 → $155 | $129.84 | +19.38% | 40 | May 27, 2026 | |
| GRAL GRAIL | Maintained: Buy | n/a | $59.85 | - | 4 | May 27, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | n/a | $469.34 | - | 39 | May 20, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $7 → $1.5 | $0.5422 | +176.65% | 11 | May 14, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $30 | $22.00 | +36.36% | 1 | May 12, 2026 | |
| XGN Exagen | Maintained: Buy | $10 → $8 | $4.67 | +71.31% | 14 | May 11, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $1.31 | +129.01% | 25 | May 8, 2026 | |
| GH Guardant Health | Rated: Buy | $135 → $127 | $131.62 | -3.51% | 18 | May 8, 2026 | |
| PSNL Personalis | Maintained: Buy | $11 → $10 | $9.59 | +4.28% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $31 | $17.97 | +72.51% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $53 → $40 | $37.06 | +7.93% | 25 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 | $212.07 | +32.03% | 25 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $25 | $28.84 | -13.31% | 32 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $373 → $385 | $355.53 | +8.29% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $4 | $3.10 | +29.03% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $17.60 | +19.32% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.87 | - | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 → $120 | $99.66 | +20.41% | 23 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $15.16 | +97.89% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $135 → $55 | $59.92 | -8.21% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.88 | - | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 → $140 | $160.97 | -13.03% | 43 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $9 | $9.39 | -4.15% | 24 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $11.15 | +25.56% | 21 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.24 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $240 | $180.10 | +33.26% | 32 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.72 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $4.33 | +61.66% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $43 | $54.23 | -20.71% | 25 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $183 | $146.24 | +25.14% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $0.8877 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $118.77 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $48.11 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $62 | $4.98 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $76.17 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $465 | $187.51 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $880 → $1,139 | $1,131.49 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 → $275 | $181.46 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $146.18 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $47.33 | n/a | 1 | Nov 26, 2013 |
Tempus AI
Jun 1, 2026
Reiterated: Buy
Price Target: $68
Current: $47.82
Upside: +42.20%
Agilent Technologies
May 27, 2026
Reiterated: Buy
Price Target: $157 → $155
Current: $129.84
Upside: +19.38%
GRAIL
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $59.85
Upside: -
Thermo Fisher Scientific
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $469.34
Upside: -
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $7 → $1.5
Current: $0.5422
Upside: +176.65%
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $22.00
Upside: +36.36%
Exagen
May 11, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.67
Upside: +71.31%
Pacific Biosciences of California
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $1.31
Upside: +129.01%
Guardant Health
May 8, 2026
Rated: Buy
Price Target: $135 → $127
Current: $131.62
Upside: -3.51%
Personalis
May 8, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $9.59
Upside: +4.28%
May 8, 2026
Maintained: Buy
Price Target: $35 → $31
Current: $17.97
Upside: +72.51%
May 7, 2026
Rated: Hold
Price Target: $53 → $40
Current: $37.06
Upside: +7.93%
May 7, 2026
Rated: Buy
Price Target: $280
Current: $212.07
Upside: +32.03%
May 7, 2026
Maintained: Hold
Price Target: $19 → $25
Current: $28.84
Upside: -13.31%
May 6, 2026
Rated: Hold
Price Target: $373 → $385
Current: $355.53
Upside: +8.29%
May 6, 2026
Rated: Hold
Price Target: $7 → $4
Current: $3.10
Upside: +29.03%
May 6, 2026
Rated: Buy
Price Target: $21
Current: $17.60
Upside: +19.32%
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.87
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $124 → $120
Current: $99.66
Upside: +20.41%
May 5, 2026
Reiterated: Buy
Price Target: $30
Current: $15.16
Upside: +97.89%
May 5, 2026
Rated: Buy
Price Target: $135 → $55
Current: $59.92
Upside: -8.21%
May 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.88
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: $118 → $140
Current: $160.97
Upside: -13.03%
Apr 29, 2026
Maintained: Hold
Price Target: $10 → $9
Current: $9.39
Upside: -4.15%
Apr 28, 2026
Maintained: Buy
Price Target: $16 → $14
Current: $11.15
Upside: +25.56%
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $2.24
Upside: -
Apr 21, 2026
Rated: Buy
Price Target: $270 → $240
Current: $180.10
Upside: +33.26%
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $1.72
Upside: -
Feb 23, 2026
Maintained: Hold
Price Target: $7
Current: $4.33
Upside: +61.66%
Feb 13, 2026
Maintained: Hold
Price Target: $53 → $43
Current: $54.23
Upside: -20.71%
Jul 14, 2025
Maintained: Hold
Price Target: $183
Current: $146.24
Upside: +25.14%
May 6, 2025
Maintained: Buy
Price Target: $2.5
Current: $0.8877
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $525
Current: $118.77
Upside: n/a
Apr 26, 2023
Maintained: Buy
Price Target: $45
Current: $48.11
Upside: n/a
Oct 15, 2021
Maintained: Buy
Price Target: $68 → $62
Current: $4.98
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $76.17
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $390 → $465
Current: $187.51
Upside: n/a
May 7, 2021
Maintained: Sell
Price Target: $880 → $1,139
Current: $1,131.49
Upside: n/a
Apr 23, 2021
Maintained: Buy
Price Target: $224 → $275
Current: $181.46
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $146.18
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $47.33
Upside: n/a